Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation.
Yan WangTengrui ZhangChen LiJia GuoBaohui XuLixiang XuePublished in: Asia-Pacific journal of clinical oncology (2021)
Telmisartan inhibits the proliferation and oncogenicity while it also increases the lipid oxidation of human GBM cells.